Clinical Trial Update: Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of once-weekly KAI-9531 in adults with obesity and diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Drugs mentioned

• KAI-9531

Snippet

Sponsor: Kailera | Conditions: Obesity With Diabetes, Overweight With Diabetes | Phase 3 | Status: RECRUITING